Summary
- Current Price
- As of today, PTHS price is $26.72, down -3.50% on
- Current Price All-Time High
- PTHS price is currently -55.47% below its historical high of $60.00 set on
- Market Cap
- PTHS current market cap is $93M, up +1366.63% over the past 365 days
- PE Ratio
- PTHS PE ratio is unknown
- Revenue
- PTHS current annual revenue is $16.80M, up +100.00% year-over-year
- Next Earnings
- As of today, the next earnings release for PTHS has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Pelthos Therapeutics Inc. |
| Ticker | NYSEAmerican: PTHS |
| Exchange | NYSE American |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | channeltherapeutics.com |
| Employees | 4 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $26.72 | ||
| Price, 1D Change | -3.50% | |
| $93M | ||
| - | ||
| - | ||
| 0.83 | ||
| $17M | ||
| Revenue, 1Y Change | +100.00% | |
| -$23.04 | ||
| EPS, 1Y Change | -61.42% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | CHRO | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$23.04 | ||
| EPS Estimate | N/A | -$10.95 |
| EPS Est. Change | N/A | +52.45% |
| $16.80M | ||
| Revenue Estimate | N/A | $60.83M |
| Revenue Est. Change | N/A | +262.17% |
| $26.72 | ||
| Price Target | - | $55.00 |
| Price Tgt. Change | - | +105.84% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$19.06 | -$23.04 | -20.87% | |
| -$10.95 | N/A | +52.45% | |
| -$0.11 | N/A | +99.54% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $16.59M | $16.80M | +1.22% | |
| $60.83M | N/A | +262.17% | |
| $111.05M | N/A | +561.21% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +178.33% | ||
| - | ||
| +1,366.63% | ||
| - | ||
| +100.00% | ||
| +100.00% | ||
| -61.42% | ||
| -5,303.68% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $26.72 | ||
| $25.93 | ||
| SMA 200 vs Price | -2.94% | |
| $23.67 | ||
| SMA 50 vs Price | -11.40% | |
| 0.83 | ||
| $1.31 | ||
| 60.93 | ||
| 56.26% | ||
| 130.72% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $16.80M | ||
| -$23.04 | ||
| $10.52M | ||
| 62.65% | ||
| -$32.43M | ||
| -193.09% | ||
| -$43.32M | ||
| -257.93% | ||
| -$30.07M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.90 | ||
| 2.03 | ||
| 1.12 | ||
| - | ||
| - | ||
| -0.53 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 5.53 | ||
| 2.39 | ||
| -3.65 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $38.88M | ||
| $18.02M | ||
| $130.40M | ||
| $52.70M | ||
| $91.52M | ||
| $25.99M | ||
| $34.83M | ||
| $635.00K | ||
| $2.99M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $60.11M | ||
| $42.95M | ||
| $6.27M | ||
| $42.45M | ||
| $2.36M | ||
| $0.00 | ||
| -$7.39M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$22.59M | ||
| -$5.24M | ||
| $45.34M | ||
| $99.00K | ||
| -$22.69M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Cantor Fitzgerald | ||
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | ||
| Roth Capital | → | |
| Oppenheimer | → | |
| Lake Street | ||
| HC Wainwright & Co. | ||
| Roth Capital | ||
| Oppenheimer | → |
Analyst sentiment
Institutional ownership
Screeners with PTHS
FAQ
What is the ticker symbol for Pelthos Therapeutics Inc.?
The ticker symbol for Pelthos Therapeutics Inc. is NYSEAmerican:PTHS
Does Pelthos Therapeutics Inc. pay dividends?
No, Pelthos Therapeutics Inc. does not pay dividends
What sector is Pelthos Therapeutics Inc. in?
Pelthos Therapeutics Inc. is in the Healthcare sector
What industry is Pelthos Therapeutics Inc. in?
Pelthos Therapeutics Inc. is in the Biotechnology industry
What country is Pelthos Therapeutics Inc. based in?
Pelthos Therapeutics Inc. is headquartered in United States
When did Pelthos Therapeutics Inc. go public?
Pelthos Therapeutics Inc. initial public offering (IPO) was on July 2, 2025
Is Pelthos Therapeutics Inc. in the S&P 500?
No, Pelthos Therapeutics Inc. is not included in the S&P 500 index
Is Pelthos Therapeutics Inc. in the NASDAQ 100?
No, Pelthos Therapeutics Inc. is not included in the NASDAQ 100 index
Is Pelthos Therapeutics Inc. in the Dow Jones?
No, Pelthos Therapeutics Inc. is not included in the Dow Jones index
When was Pelthos Therapeutics Inc. last earnings report?
Pelthos Therapeutics Inc.'s most recent earnings report was on May 14, 2026
When does Pelthos Therapeutics Inc. report earnings?
The date for Pelthos Therapeutics Inc.'s next earnings report has not been announced yet
Data Sources & References
- PTHS Official Website channeltherapeutics.com
- PTHS Profile on Yahoo Finance finance.yahoo.com/quote/PTHS
- PTHS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pths